TU Darmstadt / ULB / TUbiblio

Inducible nuclear import by TetR aptamer-controlled 3' splice site selection.

Mol, Adam ; Vogel, Marc ; Suess, Beatrix (2021)
Inducible nuclear import by TetR aptamer-controlled 3' splice site selection.
In: RNA (New York, N.Y.), 27 (2)
doi: 10.1261/rna.077453.120
Artikel, Bibliographie

Kurzbeschreibung (Abstract)

Correct cellular localization is essential for the function of many eukaryotic proteins and hence cell physiology. Here, we present a synthetic genetic device that allows to control nuclear and cytosolic localization based on controlled alternative splicing in human cells. The device is based on the fact that an alternative 3' splice site is located within a TetR aptamer that in turn is positioned between the branch point and the canonical splice site. The novel splice site is only recognized when the TetR repressor is bound. Addition of doxycycline prevents TetR aptamer binding and leads to recognition of the canonical 3' splice site. It is thus possible to produce two independent splice isoforms. Since the terminal loop of the aptamer may be replaced with any sequence of choice, one of the two isoforms may be extended by the respective sequence of choice depending on the presence of doxycycline. In a proof-of-concept study, we fused a nuclear localization sequence to a cytosolic target protein, thus directing the protein into the nucleus. However, the system is not limited to the control of nuclear localization. In principle, any target sequence can be integrated into the aptamer, allowing not only the production of a variety of different isoforms on demand, but also to study the function of mislocalized proteins. Moreover, it also provides a valuable tool for investigating the mechanism of alternative splicing in human cells.

Typ des Eintrags: Artikel
Erschienen: 2021
Autor(en): Mol, Adam ; Vogel, Marc ; Suess, Beatrix
Art des Eintrags: Bibliographie
Titel: Inducible nuclear import by TetR aptamer-controlled 3' splice site selection.
Sprache: Englisch
Publikationsjahr: Februar 2021
Titel der Zeitschrift, Zeitung oder Schriftenreihe: RNA (New York, N.Y.)
Jahrgang/Volume einer Zeitschrift: 27
(Heft-)Nummer: 2
DOI: 10.1261/rna.077453.120
Kurzbeschreibung (Abstract):

Correct cellular localization is essential for the function of many eukaryotic proteins and hence cell physiology. Here, we present a synthetic genetic device that allows to control nuclear and cytosolic localization based on controlled alternative splicing in human cells. The device is based on the fact that an alternative 3' splice site is located within a TetR aptamer that in turn is positioned between the branch point and the canonical splice site. The novel splice site is only recognized when the TetR repressor is bound. Addition of doxycycline prevents TetR aptamer binding and leads to recognition of the canonical 3' splice site. It is thus possible to produce two independent splice isoforms. Since the terminal loop of the aptamer may be replaced with any sequence of choice, one of the two isoforms may be extended by the respective sequence of choice depending on the presence of doxycycline. In a proof-of-concept study, we fused a nuclear localization sequence to a cytosolic target protein, thus directing the protein into the nucleus. However, the system is not limited to the control of nuclear localization. In principle, any target sequence can be integrated into the aptamer, allowing not only the production of a variety of different isoforms on demand, but also to study the function of mislocalized proteins. Moreover, it also provides a valuable tool for investigating the mechanism of alternative splicing in human cells.

ID-Nummer: pmid:33148600
Zusätzliche Informationen:

First published online, November 2020.

Fachbereich(e)/-gebiet(e): 10 Fachbereich Biologie
10 Fachbereich Biologie > Synthetic RNA biology
Hinterlegungsdatum: 10 Nov 2020 06:41
Letzte Änderung: 25 Jul 2023 08:30
PPN:
Export:
Suche nach Titel in: TUfind oder in Google
Frage zum Eintrag Frage zum Eintrag

Optionen (nur für Redakteure)
Redaktionelle Details anzeigen Redaktionelle Details anzeigen